Direct interaction of hematopoietic transcription factors PU.1 and GATA- 1: Functional antagonism in erythroid cells

Natasha Rekhtman, Farshid Radparvar, Todd Evans, Arthur I. Skoultchi

Research output: Contribution to journalArticle

355 Citations (Scopus)

Abstract

Malignant transformation usually inhibits terminal cell differentiation but the precise mechanisms involved are not understood. PU.1 is a hematopoietic-specific Ets family transcription factor that is required for development of some lymphoid and myeloid lineages. PU.1 can also act as an oncoprotein as activation of its expression in erythroid precursors by proviral insertion or transgenesis causes erythroleukemias in mice. Restoration of terminal differentiation in the mouse erythroleukemia (MEL) cells requires a decline in the level of PU.1, indicating that PU.1 can block erythroid differentiation. Here we investigate the mechanism by which PU.1 interferes with erythroid differentiation. We find that PU.1 interacts directly with GATA-1, a zinc finger transcription factor required for erythroid differentiation. Interaction between PU.1 and GATA-1 requires intact DNA-binding domains in both proteins. PU.1 represses GATA-l-mediated transcriptional activation. Both the DNA binding and transactivation domains of PU.1 are required for repression and both domains are also needed to block terminal differentiation in MEL cells. We also show that ectopic expression of PU.1 in Xenopus embryos is sufficient to block erythropoiesis during normal development. Furthermore, introduction of exogenous GATA-1 in both MEL cells and Xenopus embryos and explants relieves the block to erythroid differentiation imposed by PU.1. Our results indicate that the stoichiometry of directly interacting but opposing transcription factors may be a crucial determinant governing processes of normal differentiation and malignant transformation.

Original languageEnglish (US)
Pages (from-to)1398-1411
Number of pages14
JournalGenes and Development
Volume13
Issue number11
StatePublished - Jun 1 1999

Fingerprint

Leukemia, Erythroblastic, Acute
Erythroid Cells
Xenopus
Transcriptional Activation
Transcription Factors
Embryonic Structures
Proto-Oncogene Proteins c-ets
Gene Transfer Techniques
Erythropoiesis
Oncogene Proteins
DNA
Zinc Fingers
Cell Differentiation
proto-oncogene protein Spi-1
Proteins

Keywords

  • Differentiation
  • Erythropoiesis
  • GATA-1
  • Murine erythroleukemia
  • PU.1

ASJC Scopus subject areas

  • Genetics
  • Developmental Biology

Cite this

Direct interaction of hematopoietic transcription factors PU.1 and GATA- 1 : Functional antagonism in erythroid cells. / Rekhtman, Natasha; Radparvar, Farshid; Evans, Todd; Skoultchi, Arthur I.

In: Genes and Development, Vol. 13, No. 11, 01.06.1999, p. 1398-1411.

Research output: Contribution to journalArticle

@article{fdbda814e15b4e32bd525f7c54602953,
title = "Direct interaction of hematopoietic transcription factors PU.1 and GATA- 1: Functional antagonism in erythroid cells",
abstract = "Malignant transformation usually inhibits terminal cell differentiation but the precise mechanisms involved are not understood. PU.1 is a hematopoietic-specific Ets family transcription factor that is required for development of some lymphoid and myeloid lineages. PU.1 can also act as an oncoprotein as activation of its expression in erythroid precursors by proviral insertion or transgenesis causes erythroleukemias in mice. Restoration of terminal differentiation in the mouse erythroleukemia (MEL) cells requires a decline in the level of PU.1, indicating that PU.1 can block erythroid differentiation. Here we investigate the mechanism by which PU.1 interferes with erythroid differentiation. We find that PU.1 interacts directly with GATA-1, a zinc finger transcription factor required for erythroid differentiation. Interaction between PU.1 and GATA-1 requires intact DNA-binding domains in both proteins. PU.1 represses GATA-l-mediated transcriptional activation. Both the DNA binding and transactivation domains of PU.1 are required for repression and both domains are also needed to block terminal differentiation in MEL cells. We also show that ectopic expression of PU.1 in Xenopus embryos is sufficient to block erythropoiesis during normal development. Furthermore, introduction of exogenous GATA-1 in both MEL cells and Xenopus embryos and explants relieves the block to erythroid differentiation imposed by PU.1. Our results indicate that the stoichiometry of directly interacting but opposing transcription factors may be a crucial determinant governing processes of normal differentiation and malignant transformation.",
keywords = "Differentiation, Erythropoiesis, GATA-1, Murine erythroleukemia, PU.1",
author = "Natasha Rekhtman and Farshid Radparvar and Todd Evans and Skoultchi, {Arthur I.}",
year = "1999",
month = "6",
day = "1",
language = "English (US)",
volume = "13",
pages = "1398--1411",
journal = "Genes and Development",
issn = "0890-9369",
publisher = "Cold Spring Harbor Laboratory Press",
number = "11",

}

TY - JOUR

T1 - Direct interaction of hematopoietic transcription factors PU.1 and GATA- 1

T2 - Functional antagonism in erythroid cells

AU - Rekhtman, Natasha

AU - Radparvar, Farshid

AU - Evans, Todd

AU - Skoultchi, Arthur I.

PY - 1999/6/1

Y1 - 1999/6/1

N2 - Malignant transformation usually inhibits terminal cell differentiation but the precise mechanisms involved are not understood. PU.1 is a hematopoietic-specific Ets family transcription factor that is required for development of some lymphoid and myeloid lineages. PU.1 can also act as an oncoprotein as activation of its expression in erythroid precursors by proviral insertion or transgenesis causes erythroleukemias in mice. Restoration of terminal differentiation in the mouse erythroleukemia (MEL) cells requires a decline in the level of PU.1, indicating that PU.1 can block erythroid differentiation. Here we investigate the mechanism by which PU.1 interferes with erythroid differentiation. We find that PU.1 interacts directly with GATA-1, a zinc finger transcription factor required for erythroid differentiation. Interaction between PU.1 and GATA-1 requires intact DNA-binding domains in both proteins. PU.1 represses GATA-l-mediated transcriptional activation. Both the DNA binding and transactivation domains of PU.1 are required for repression and both domains are also needed to block terminal differentiation in MEL cells. We also show that ectopic expression of PU.1 in Xenopus embryos is sufficient to block erythropoiesis during normal development. Furthermore, introduction of exogenous GATA-1 in both MEL cells and Xenopus embryos and explants relieves the block to erythroid differentiation imposed by PU.1. Our results indicate that the stoichiometry of directly interacting but opposing transcription factors may be a crucial determinant governing processes of normal differentiation and malignant transformation.

AB - Malignant transformation usually inhibits terminal cell differentiation but the precise mechanisms involved are not understood. PU.1 is a hematopoietic-specific Ets family transcription factor that is required for development of some lymphoid and myeloid lineages. PU.1 can also act as an oncoprotein as activation of its expression in erythroid precursors by proviral insertion or transgenesis causes erythroleukemias in mice. Restoration of terminal differentiation in the mouse erythroleukemia (MEL) cells requires a decline in the level of PU.1, indicating that PU.1 can block erythroid differentiation. Here we investigate the mechanism by which PU.1 interferes with erythroid differentiation. We find that PU.1 interacts directly with GATA-1, a zinc finger transcription factor required for erythroid differentiation. Interaction between PU.1 and GATA-1 requires intact DNA-binding domains in both proteins. PU.1 represses GATA-l-mediated transcriptional activation. Both the DNA binding and transactivation domains of PU.1 are required for repression and both domains are also needed to block terminal differentiation in MEL cells. We also show that ectopic expression of PU.1 in Xenopus embryos is sufficient to block erythropoiesis during normal development. Furthermore, introduction of exogenous GATA-1 in both MEL cells and Xenopus embryos and explants relieves the block to erythroid differentiation imposed by PU.1. Our results indicate that the stoichiometry of directly interacting but opposing transcription factors may be a crucial determinant governing processes of normal differentiation and malignant transformation.

KW - Differentiation

KW - Erythropoiesis

KW - GATA-1

KW - Murine erythroleukemia

KW - PU.1

UR - http://www.scopus.com/inward/record.url?scp=0033151624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033151624&partnerID=8YFLogxK

M3 - Article

C2 - 10364157

AN - SCOPUS:0033151624

VL - 13

SP - 1398

EP - 1411

JO - Genes and Development

JF - Genes and Development

SN - 0890-9369

IS - 11

ER -